BioMoti today announces the appointment of Dr Michael O’Neill to its business advisory board. Dr O’Neill is currently Managing Director at Eolas Biosciences and brings over 20 years experience in the pharmaceutical industry, working for Merck, Laboratorios Almirall and Eli Lilly.

Dr Ateh, CEO of BioMoti said: “I am very happy to welcome Dr O’Neill to BioMoti, his expertise in preclinical stages of drug development and experience with other start-up projects will be invaluable moving forward.”